Upgrade to SI Premium - Free Trial

Regeneron Pharma (REGN) PT Raised to $995 at Guggenheim

April 30, 2026 2:49 PM
Guggenheim analyst Yatin Suneja raised the price target on Regeneron Pharma (NASDAQ: REGN) to $995.00 (from $975.00) while maintaining a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change